EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY

被引：0
|
作者：
Saliba, F. [1 ]
Duvoux, C. [2 ]
Durand, F. [3 ]
Neau-Cransac, M. [4 ]
Hardwigsen, J. [5 ]
Pageaux, G. [6 ]
Di Giambattista, F. [7 ]
机构：
[1] Hop Paul Brousse, Villejuif, France
[2] Hop Henri Mondor, F-94010 Creteil, France
[3] Hop Beaujon, Clichy, France
[4] Hop Pellegrin, F-33076 Bordeaux, France
[5] Hop Conception, Marseille, France
[6] Hop St Eloi, Montpellier, France
[7] Novartis Pharma SAS, Rueil Malmaison, France
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
74
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [41] Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study
    Fung, J.
    Saliba, F.
    Kaiser, G.
    De Carlis, L.
    Metselaar, H.
    Nevens, F.
    Duvoux, C.
    De Simone, P.
    Fischer, L.
    Dong, G.
    Rauer, B.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 180 - 180
  • [42] THE TRANSFORM STUDY: 12-MONTH EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pascual, Julio
    Berger, Stefan
    Witzke, Oliver
    Chadban, Steve
    Oppenheimer, Federico
    Oberbauer, Rainer
    Watarai, Yoshihiko
    Legendre, Christophe
    Luo, Wen-Lin
    Marti, Anamaria
    Bernhardt, Peter
    Tedesco, Helio
    TRANSPLANT INTERNATIONAL, 2017, 30 : 159 - 159
  • [43] Renal Function and HCC Recurrence As Well As Safety of Everolimus with Reduced Tacrolimus Versus Standard Tacrolimus in Deceased and Living Donor Liver Transplant Recipients: Pooled Analysis of H2304 and H2307 Studies
    Lee, Sung Gyu
    Jeng, Long Bin
    Saliba, Faouzi
    Soin, Arvinder Singh
    Lee, Wei-Chen
    De Simone, Paolo
    Nevens, Frederik
    Suh, Kyung-Suk
    Fischer, Lutz
    Joo, DongJin
    Fung, John J.
    Joh, Jae-Won
    Kaido, Toshimi
    Grant, David R.
    Meier, Matthias
    Barbara, Rauer
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary A.
    HEPATOLOGY, 2018, 68 : 6A - 6A
  • [44] Efficacy and Safety of Everolimus with Reduced-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Results from the TRANSFORM Study
    Pascual, Julio
    Chadban, Steve
    Tedesco, Helio
    Berger, Stefan
    Qazi, Yasir
    Cruzado, Josep M.
    Bernhardt, Peter
    Legendre, Christophe
    Kim, Myoung Soo
    Vincenti, Flavio
    TRANSPLANTATION, 2018, 102 : S367 - S368
  • [45] Improvement of renal function with everolimus plus reduced tacrolimus in de novo liver transplant recipients - HEPHAISTOS study 12 month data.
    Schlitt, H. J.
    Nashan, B.
    Braun, F.
    Pascher, A.
    Klein, C. -G
    Neumann, U.
    Kroeger, I
    Wimmer, P.
    Schemmer, P.
    TRANSPLANTATION, 2019, 103 (08) : 46 - 46
  • [46] Everolimus Monotherapy after Tacrolimus Withdrawal at Month 4 after Liver Transplantation: 3-Year Results from the H2304 Study Extension.
    Fung, J.
    Metselaar, H. J.
    Koneru, B.
    Bartels, M.
    McCaughan, G.
    Chavin, K.
    Dong, G.
    Rauer, B.
    Junge, G.
    Fischer, L.
    LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
  • [47] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANTATION: 3-YEAR RESULTS FROM H2304 STUDY EXTENSION
    Saliba, F.
    Kaiser, G. M.
    De Carlis, L.
    Metselaar, H. J.
    De Simone, P.
    Duvoux, C.
    Nevens, F.
    Fischer, L.
    Fung, J.
    Dong, G.
    Rauer, B.
    Junge, G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S362 - S362
  • [48] Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study.
    Saito, K.
    Uchida, K.
    Takahara, S.
    Yoshimura, N.
    Teraoka, S.
    Cornu-Artis, C.
    Kobayashi, E.
    Takahashi, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 314 - 314
  • [49] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [50] EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IMPROVES KIDNEY FUNCTION VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Braun, F.
    Nashan, B.
    Pascher, A.
    Klein, C. G.
    Schemmer, P.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Schlitt, H. J.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 24 - 24
12345